In silico error correction improves cfDNA mutation calling.
|dc.contributor.author||Kim Chang, S|
|dc.contributor.author||Rothwell, Dominic G|
|dc.contributor.author||Miller, Crispin J|
|dc.identifier.citation||Kim CS, Mohan S, Ayub M, Rothwell DG, Dive C, Brady G, et al. In silico error correction improves cfDNA mutation calling. Bioinformatics. 2018 Dec 6.||en|
|dc.description.abstract||Motivation: Circulating-free DNA (cfDNA) profiling by sequencing is an important minimally invasive protocol for monitoring the mutation profile of solid tumours in cancer patients. Since the concentration of available cfDNA is limited, sample library generation relies on multiple rounds of PCR amplification, during which the accumulation of errors results in reduced sensitivity and lower accuracy.Results: We present PCR Error Correction (PEC), an algorithm to identify and correct errors in short read sequencing data. It exploits the redundancy that arises from multiple rounds of PCR amplification. PEC is particularly well suited to applications such as single-cell sequencing and circulating tumour DNA (ctDNA) analysis, in which many cycles of PCR are used to generate sufficient DNA for sequencing from small amounts of starting material. When applied to ctDNA analysis, PEC significantly improves mutation calling accuracy, achieving similar levels of performance to more complex strategies that require additional protocol steps and access to calibration DNA datasets. Availability and implementation: PEC is available under the GPL-v3 Open Source licence, and is freely available from: https://github.com/CRUKMI-ComputationalBiology/PCR_Error_Correction.git. Supplementary information: Supplementary figures are available at Bioinformatics online.||en|
|dc.title||In silico error correction improves cfDNA mutation calling.||en|
|dc.contributor.department||Clinical and Experimental Pharmacology Group, University of Manchester, Alderley Park, Manchester, UK||en|